Stay updated on Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial
Sign up to get notified when there's something new on the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page.

Latest updates to the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page
- ChecktodayChange DetectedRevision: v3.6.6 is now displayed, replacing Revision: v3.6.5. This indicates a minor site version update to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedFooter now displays Revision: v3.6.5, replacing Revision: v3.6.4, signaling a new site build.SummaryDifference0.1%

- Check36 days agoChange DetectedThe site’s version label updated from v3.6.3 to v3.6.4, indicating a platform update. The change is primarily a backend/version bump and does not alter the visible study details or results page.SummaryDifference0.1%

- Check57 days agoChange DetectedThe footer now shows Revision: v3.6.3, replacing the previous version, indicating a minor site update to the revision history.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now displays Revision: v3.6.2 instead of Revision: v3.6.0, indicating a software release version. This update reflects an infrastructure or UI deployment rather than changes to the study results or page content.SummaryDifference0.1%

- Check79 days agoChange DetectedThe recruitment status now reads 'No longer looking for participants', indicating enrollment for the study is closed. The page has also been updated to Revision: v3.6.0.SummaryDifference0.5%

Stay in the know with updates to Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Immunogenicity of VLA2001 in Adults Aged ≥56 Years Clinical Trial page.